Patent Expiry

Patent/Exclusivity Expiry: ZEJULA

Drug
ZEJULA

Other upcoming events for IMNN

Phase 3 ReadoutPhase 3 Topline: A Randomized Phase 3 Trial Evaluating the Safety & Efficacy of IP IMNN-001 Administered in Combinati
Patent ExpiryPatent/Exclusivity Expiry: AKEEGA

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: ZEJULA — IMNN Patent Expiry | BioSniper